Diagnostic News and Research

RSS

Positive preclinical data on Aeterna Zentaris' AEZS-130/Ghrelin Receptor Agonist presented at ENDO meeting

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, was presented yesterday at the 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which is held through June 22, 2010 at the San Diego Convention Center in San Diego, California.

21 Jun 2010

Toshiba's Aquilion ONE dynamic volume CT system improves clinical pathway for patients in ERs

Emergency departments are challenged to streamline patient diagnoses and treatment for a variety of conditions and require a CT system capable of imaging patients quickly, accurately and safely. Toshiba America Medical Systems, Inc.'s Aquilion® ONE 320-detector row CT system is designed for such settings and used to evaluate a range of patients, including cardiac, neuro, stroke and pediatric.

21 Jun 2010

Severity of appendicitis can be predicted from blood sample, shows thesis

The symptoms of appendicitis are often diffuse and it can be difficult to obtain an accurate diagnosis early in the course of the disease. It may be possible to predict the severity from a blood sample, and in this way determine the treatment on an individual basis. This is the conclusion of a thesis presented at the University of Gothenburg, sweden.

21 Jun 2010

Exiqon licenses LNA technology to BD for diagnosing infectious diseases

Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.

From BD (Becton, Dickinson and Company) 21 Jun 2010

AdnaGen signs option agreement to license specific antibodies to KellBenx

AdnaGen AG, a subsidiary of OncoVista Innovative Therapies, Inc., a high-growth global biotech company developing proprietary, leading-edge early detection and drug technologies to enable safe, targeted personal cancer treatments, today announced that it has entered into an option agreement to license specific antibodies to KellBenx Inc., a New York-based private biotech firm.

19 Jun 2010

LUHS opens clinic to treat debilitating effects of CPP in women

Loyola University Health System has opened a clinic to treat the debilitating effects of chronic pelvic pain in women. The clinic is located at the Loyola Outpatient Center at 2160 S. First Ave., in Maywood.

19 Jun 2010

9th INT'L BIO FORUM & BIO EXPO JAPAN from June 30 - July 2, 2010

9th INT'L BIO FORUM & BIO EXPO JAPAN, organized by Reed Exhibitions Japan, will come back again as Asia's largest bio-event from June 30 - July 2, 2010. "Gene diagnosis" is one of the featured topics for this year.

18 Jun 2010

Completion of drug analysis by PBS-Bio enables PharmaGap advance development of novel anti-cancer drug

Predictive Biomarker Sciences Inc. (PBS-Bio) has completed its first drug analysis, enabling Canadian biotech company PharmaGap Inc. to significantly advance a potentially significant anti-cancer medication.

18 Jun 2010

New multimillion dollar BSL-3 laboratory complex at Nigerian National TB and Leprosy Training Center

This week, the U.S. Centers for Disease Control (CDC) Director, Dr. Tom Frieden, visited the Nigerian National TB and Leprosy Training Center (NTBLTC) to tour a multimillion dollar laboratory complex established by the Institute of Human Virology (IHV) of the University of Maryland School of Medicine in Baltimore, Maryland, and the Institute of Human Virology-Nigeria. This U.S.-Nigeria partnership was established in 2004 through funding from the CDC and the President's Emergency Plan For AIDS Relief (PEPFAR).

18 Jun 2010

Review of possible uses, limits of WB-MRI procedure

Thanks to technical progress, there are now new areas in which whole body magnetic resonance imaging can be used. In the current edition of Deutsches -rzteblatt International (Dtsch Arztebl Int 2010; 107[22]: 383-9), Gerwin Schmidt and his coauthors present a review of possible uses, together with the limits of this radiation-free diagnostic procedure.

18 Jun 2010

IMGM acquires 3,100,000 Class B Preferred Shares of Positron

The Shareholders of Imagin Molecular Corporation ("IMGM") have approved, through a consent of over 51% of shareholder vote, certain transactions wherein IMGM completed the acquisition of 3,100,000 Class B Preferred Shares of Positron Corporation which shares are convertible on a 1 for 100 basis into Positron common shares.

18 Jun 2010

Possible mechanism identified for how lithium treats bipolar disorder

Lithium has been established for more than 50 years as one of the most effective treatments for manic depression, clinically termed bipolar disorder. However, scientists have never been entirely sure exactly why it is beneficial.

18 Jun 2010

Neonatal diarrhea may lead to life threatening dehydration and malnutrition: Research

Diarrhea represents a major condition responsible for pediatric mortality worldwide. The onset of neonatal diarrhea may rapidly lead to life threatening dehydration and malnutrition. Clinical and epidemiologic studies defining severity and etiology are needed in order to improve diagnostic and therapeutic approaches for the management of neonatal diarrhea.

18 Jun 2010

Research identifies early biomarker for insulin resistance, glucose intolerance in nondiabetic population

Metabolon, Inc., the leader in metabolomics-based biomarker discovery and analysis, today announced the publication of research that identified a novel, early biomarker for insulin resistance and glucose intolerance in a nondiabetic population.

17 Jun 2010

Merge Healthcare announces new distribution agreement with Microdata Tecnologia

Merge Healthcare, a leading health IT solutions provider , today announced a new distribution agreement with Microdata Tecnologia LTDA, a PACS and Medical Imaging Technology manufacturer in Brazil. Under the agreement, Microdata Tecnologia LTDA will have exclusive access to a Portuguese language version of eFilm Workstation, the world's most downloaded software for viewing medical images.

17 Jun 2010

NuGEN Technologies receives State of California cGMP certification

NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.

17 Jun 2010

St. Jude Medical's EnSite Contact Technology platform receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of the EnSite Contact™ Technology platform at the 17th World Congress in Cardiac Electrophysiology and Cardiac Techniques (CardioStim).

17 Jun 2010

FDA seeks public input on regulation of laboratory-developed tests

The U.S. Food and Drug Administration today announced plans to hold a public meeting on July 19-20, 2010, to discuss how the agency will oversee laboratory-developed tests (LDTs).

17 Jun 2010

dabl's computerised system prevents misdiagnosis of ABPM

An independent study has revealed that Irish Company, dabl's computerised system for diagnosing 24 hour blood pressure is more accurate and consistent than a leading group of international hypertension experts.

17 Jun 2010

Researchers identify peptide that triggers diabetes

Researchers at National Jewish Health and the University of Colorado Anschutz Medical Campus have identified the precise protein fragment, or peptide, that can trigger diabetes in mice. The finding, published in the June 15, 2010, issue of the Proceedings of the National Academy of Sciences, supports an emerging theory about the origins of autoimmunity, and may lead to new diagnostic and therapeutic strategies in humans.

17 Jun 2010